Global Pemphigus Vulgaris Treatment Market Is Anticipated To Witness High Growth Due To Rising R&D Activities And Growing Demand For Pemphigus Vulgaris Treatment Methods
Overview:
Pemphigus Vulgaris is an autoimmune disease that causes blisters to form on the skin and mucous membranes. The blisters are filled with clear fluid and easily rupture. They appear as itchy, scaly, or crusted skin lesions that usually begin on the face, scalp, back, and upper chest. Blisters typically come and go over time, although they can be very painful.
Doctors may also suggest medicines for helping the body control the immune system, which can stop the skin and mouth from getting infected. These medicines are called immunosuppressants. Immunosuppressants are glucocorticoids, steroids, and other medications that suppress the immune system. Rituximab can also be used, which is a type of anti-cancer drug that has shown some effectiveness in treating pemphigus vulgaris and other autoimmune diseases.
Market Dynamics:
Growing investments are estimated to augment growth of the global Pemphigus Vulgaris Treatment Market over the forecast period. For instance, The Chan Zuckerberg Initiative announced a donation of USD 1.3 million to the EURORDIS-Rare Diseases Europe and the National Organization for Rare Disorders in June 2020. This will support the developmental activities and awareness campaigns associated with rare illnesses. Moreover, lack of awareness is anticipated to restrain growth of the global pemphigus vulgaris treatment for market over the forecast period.
Impact of COVID-19:
COVID-19 affected almost all sectors of society and had a long-term impact on many industries. Many industries were forced to shut down their operations temporarily, owing to strict lockdowns imposed in many regions. People across the world were suffering from this outbreak and it impacted several lives.
Patients suffering from COVID-19 were at a huge risk of extensive lung damage and this can be extremely harmful for pemphigus vulgaris patients. Also, during the pandemic doctors were focusing on COVID-19 patients and other treatments were delayed. This affected many patients undergoing several treatments. Thus, the pandemic had a negative impact on the growth of the global pemphigus vulgaris treatment for market.
Key Takeaways:
The global Pemphigus Vulgaris Treatment Market is expected to witness high growth, exhibiting CAGR of 10.5% over the forecast period, due to growing research and developmental activities by key players.
For instance, Cabaletta Bio, Inc., declared that they are focusing on discovery and development of engineered T cell therapies for patients suffering from B cell-mediated autoimmune diseases in December 2021.
North America is anticipated to witness significant growth in the global pemphigus vulgaris treatment for market over the forecast period, owing to growing healthcare expenditure, and increasing presence of major players.
Major players operating in the global Pemphigus Vulgaris Treatment Market are Accord Healthcare, Inc., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Abbvie Inc., AstraZeneca, Novartis AG, Teva Pharmaceuticals Industries Ltd, Lilly, Boehringer Ingelheim International GmbH, Fresenius Kabi AG, and Merck & Co Inc.

Comments
Post a Comment